Want to see CCLD full AI Analyst Report?
CCLD Stock Chart & Stats
$3.07
-$0.09(-2.65%)
At close: 4:00 PM EST
$3.07
-$0.09(-2.65%)
Day’s Range― - ―
52-Week Range$2.09 - $4.01
Previous CloseN/A
Volume28.18K
Average Volume (3M)620.83K
Market Cap
$94.33M
Enterprise Value$94.95M
Total Cash (Recent Filing)$3.85M
Total Debt (Recent Filing)$5.74M
Price to Earnings (P/E)27.9
Beta1.92
Next Earnings
Jul 30, 2026EPS Estimate
0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.08
Shares Outstanding42,492,950
10 Day Avg. Volume269,549
30 Day Avg. Volume620,832
Financial Highlights & Ratios
PEG Ratio-0.22
Price to Book (P/B)18.55
Price to Sales (P/S)9.16
P/FCF Ratio53.74
Enterprise Value/Market Cap1.01
Enterprise Value/Revenue0.76
Enterprise Value/Gross Profit2.42
Enterprise Value/Ebitda3.35
Forecast
1Y Price Target
$5.25Price Target Upside71.01% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.19
Revenue Forecast (FY)$130.94M
Bulls Say, Bears Say
Bulls Say
Cash GenerationConsistent operating cash flow and TTM free cash flow about equal to net income indicate durable cash conversion. This supports reinvestment in AI and product modernization, services scaling, and debt service capacity, reducing reliance on external financing over the medium term.
Capital Structure SimplificationReplacing higher-cost capital with a $50M facility and redeeming Series B removes preferred overhang and recurring dividends, lowering financing costs and clarifying the equity base. This enhances financial flexibility for integration and growth investments without immediate common dilution.
AI Commercialization & TAM ExpansionA commercially deployed AI product that automates ~75% of inbound calls indicates scalable differentiation and operational leverage. Coupled with expansion into inpatient markets via acquisitions, this increases stickiness, cross-sell potential and addressable market, supporting sustainable recurring revenue growth.
Bears Say
Gross-margin CompressionSustained gross-margin pressure erodes the company's margin buffer and limits downstream EBITDA and net income expansion. If driven by mix shifts, higher service costs, or acquisition amortization, it can blunt the benefit of revenue growth and delay durable margin recovery until cost or pricing actions take effect.
Medsphere Modernization RiskLarge-scale platform modernization and RCM carryforward items create execution risk, resource diversion, and extended timelines before full cross-sell and margin synergies realize. These are structural integration challenges that can depress margins and growth realization for many quarters.
Tight Near-term Liquidity & Debt ServiceRelatively low cash balances alongside new term loan payments raise liquidity sensitivity to revenue or FCF hiccups. This constrains discretionary spending on modernization and sales initiatives and increases the importance of predictable recurring revenue to cover fixed financing requirements over the medium term.
CareCloud News
CCLD FAQ
What was Carecloud, Inc.’s price range in the past 12 months?
Carecloud, Inc. lowest stock price was $2.09 and its highest was $4.01 in the past 12 months.
What is Carecloud, Inc.’s market cap?
Carecloud, Inc.’s market cap is $94.33M.
When is Carecloud, Inc.’s upcoming earnings report date?
Carecloud, Inc.’s upcoming earnings report date is Jul 30, 2026 which is in 26 days.
How were Carecloud, Inc.’s earnings last quarter?
Carecloud, Inc. released its earnings results on May 07, 2026. The company reported -$0.01 earnings per share for the quarter, missing the consensus estimate of -$0.007 by -$0.003.
Is Carecloud, Inc. overvalued?
According to Wall Street analysts Carecloud, Inc.’s price is currently Undervalued.
Does Carecloud, Inc. pay dividends?
Carecloud, Inc. does not currently pay dividends.
What is Carecloud, Inc.’s EPS estimate?
Carecloud, Inc.’s EPS estimate is 0.02.
How many shares outstanding does Carecloud, Inc. have?
Carecloud, Inc. has 42,492,950 shares outstanding.
What happened to Carecloud, Inc.’s price movement after its last earnings report?
Carecloud, Inc. reported an EPS of -$0.01 in its last earnings report, missing expectations of -$0.007. Following the earnings report the stock price went down -17.391%.
Which hedge fund is a major shareholder of Carecloud, Inc.?
Currently, no hedge funds are holding shares in CCLD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
CareCloud Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$5.25 (71.01% Upside)
$5.25 (71.01% Upside)
Blogger Sentiment
Bullish
CCLD Sentiment 70%
Sector Average ―
Sector Average ―
Crowd Wisdom
Positive
Last 7 Days ▼ 1.3%
Last 30 Days ▲ 4.1%
Last 30 Days ▲ 4.1%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-9.38%
12-Months-Change
Fundamentals
Return on Equity
16.87%
Trailing 12-Months
Asset Growth
17.90%
Trailing 12-Months
Company Description
Carecloud, Inc.
CareCloud, Inc. operates as a specialized healthcare technology firm, delivering a comprehensive portfolio of cloud-powered solutions and related professional services. Its primary clientele consists of medical providers and hospitals throughout the United States. The company strategically organizes its activities into two core divisions: Healthcare IT and Medical Practice Management. Through its Software-as-a-Service (SaaS) platform, CareCloud provides essential tools for managing revenue cycles, administering practices, handling electronic health records, gleaning business insights, facilitating telehealth, and enhancing patient engagement. These offerings, complemented by various software utilities and tailored business services, are designed to empower diverse medical groups and health systems. Professionals such as doctors, nurses, physician assistants, and other clinical staff who render billable services are among its key users. Established in 1999 and based in Somerset, New Jersey, the entity was originally named MTBC, Inc. before officially adopting CareCloud, Inc. in March 2021.
CCLD Company Deck
CCLD Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a broadly positive operational and strategic picture: double-digit revenue growth (13% Y/Y), commercialization and scaling of AI products (StratusAI handling ~75% of inbound calls for early adopters), successful capital structure simplification (new $50M facility and Series B redemption with no common dilution), and reaffirmation of full-year guidance with a forecasted >100% EPS improvement versus 2025. Offsetting these positives are near-term integration and amortization headwinds from the Medsphere acquisition, a drop in free cash flow and modest declines in certain adjusted metrics; management expects margins and cash generation to improve as integration and amortization effects subside and AI and cross-sell synergies ramp in the back half of the year. On balance, the call conveys momentum and clear strategic progress despite expected short-term integration costs.View all CCLD earnings summariesCCLD Stock 12 Month Forecast
Average Price Target
$5.25
▲(71.01% Upside)
Technical Analysis
Ownership Overview
1.69% Insiders
6.25% Mutual Funds
7.77% Other Institutional Investors
78.51% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---